A double-blind, placebo-controlled multi-centre study to evaluate the efficacy and tolerability of Paroxetine in the treatment of post-stroke depression.
Major Depressive Disorder
Phase 3
The data from this study is provided in combined datasets containing data from other paroxetine studies. An annotated case report form is not available for this study. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
May 2014